The treatment of Tourette's syndrome: current opinions (Q34706905)

4 August 2017

1 reference

title

The treatment of Tourette's syndrome: current opinions (English)

1 reference

4 August 2017

1 reference

Kirsten R Müller-Vahl

series ordinal

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Expert Opinion on Pharmacotherapy

4 August 2017

published in

1 reference

4 August 2017

volume

3

1 reference

4 August 2017

issue

7

1 reference

4 August 2017

page(s)

899-914

1 reference

An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Current issues in Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Tourette syndrome, associated conditions and the complexities of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Tourette syndrome: clinical characteristics and current management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: an open pilot dose-titration study with risperidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Quetiapine treatment of children with Tourette's syndrome: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Treatment approaches in Gilles de la Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Long-term effects of tetrabenazine in hyperkinetic movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Clonidine in Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

A case of Gilles de la Tourette's syndrome treated with clonazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Gilles de la Tourette syndrome. Effect of nicotine, alcohol and marihuana on clinical symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Botulinum toxin in the treatment of dystonic tics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Botulinum toxin in the treatment of tics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Vocal tics in Gilles de la Tourette syndrome treated with botulinum toxin injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Cannabinoid receptor localization in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Effective treatment of Tourette's syndrome with marijuana.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Naltrexone decreases self-injurious behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Naltrexone suppresses abnormal sexual behavior in Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Naltrexone and Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

A controlled trial of propoxyphene and naltrexone in patients with tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Naloxone in Gilles de la Tourette's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

The cause of blepharospasm is unknown in most cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Opiate therapy and self-harming behavior in Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Control of Tourette's syndrome with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Neurosurgical treatment of Tourette's syndrome: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Immediate and long term outcome after infrathalamic and thalamic lesioning for intractable Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

The effect of central nervous system stimulants on tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Stimulant medications precipitate Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Treatment of ADHD in children with tics: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

Risperidone for Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.899

21 January 2018

Identifiers

DOI

10.1517/14656566.3.7.899

1 reference

4 August 2017

1 reference